Effectiveness of the A3 robot on lower extremity motor function in stroke patients: A prospective, randomized controlled trial

Table 3 Comparison of the amount of change in clinical outcomes

Change	A3 group	Control group	P value
BADL	19.286 ± 12.150	3.518 ± 4.344	< 0.01
SSQOL	22.571 ± 7.988	4.074 ± 2.510	< 0.01
FM balance meter	1.214 ± 0.832	0.185 ± 0.396	< 0.01
FMA	3.500 ± 3.805	0.963 ± 2.084	< 0.01
RMI	2.071 ± 1.215	0.407 ± 0.572	< 0.01
HWAS	0.893 ± 0.629	0.111 ± 0.320	< 0.01
TUG	12.376 ± 8.997	2.801 ± 3.430	< 0.01
Stride frequency	18.839 ± 11.236	3.796 ± 10.829	< 0.01
Stride speed	45.125 ± 69.409	8.407 ± 10.202	0.009
Stride length	29.446 ± 16.624	8.685 ± 10.736	< 0.01
Lng	435.250 ± 570.537	66.666 ± 517.694	0.015
Area	908.678 ± 972.848	410.037 ± 1186.491	0.094
TL index	0.451 ± 0.543	0.012 ± 0.732	0.014

Data shown are mean ± SD, P values are from t-test. Area: Gravity center moving track area; BADL: Basic activities of daily living; FMA: Fugl-Meyer-Assessment scores; HWAS: Holden Walking Ability Scale; Lng: Gravity center moving track length; RMI: Rivermead Mobility Index; SSQOL: Stroke-Specific Quality of Life Scale; TL index: Track length per unit area; TUG: Time Up and Go test.